SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
522Another way around the XOMA cell expression patents ? Message 18944751nigel bates-5/14/2003
521Human Genome Sciences Acquires License from Abgenix For Human Monoclonal Antibodnigel bates-5/12/2003
520Anticancer Antibodies Message 18933234Icebrg-5/11/2003
519At least it will help their net earnings this year...nigel bates-5/8/2003
518Protein Design Labs Says It Has Stopped Development of Anti-IL-4 Antibody FollowIcebrg-5/8/2003
517Novartis puts another MEDX MAb into the clinic: Message 18916843nigel bates-5/6/2003
516Medarex Announces Antibody Development Partnership With Pfizer Wednesday April 1Icebrg-4/16/2003
515>> were these "subsequent refinements, more happenings", continuscaram(o)uche-4/12/2003
514Apologies? Appreciate being asked for clarity, but also believe that I couldn&#scaram(o)uche-4/12/2003
513I knew we could rely on you; all is now crystal clear. Actually, I meant to asknigel bates-4/12/2003
512Now were these "subsequent refinements, more happenings", continuous Biotech Jim-4/11/2003
511>> I'm sure Rick will explain the significance of this. << Yes,scaram(o)uche-4/11/2003
510Kefei Yu, Frederic Chedin, Chih-Lin Hsieh, Thomas E. Wilson, Michael R. Lieber, nigel bates-4/8/2003
509The market seemed to be listening to you yesterday. :-)nigel bates-4/3/2003
508>>Other thing I noticed from the MEDX 10K is that they are forecasting havIcebrg-4/2/2003
507Diversa enter the space (and seemingly won't have to pay XOMA royalties) - nigel bates-4/2/2003
506Other thing I noticed from the MEDX 10K is that they are forecasting having exhanigel bates-4/2/2003
505Nigel, >>The market is saying that '-010 is rather more ho-hum than &Icebrg-4/1/2003
504>>I don't buy Genmab as 'diversification' - surely a MEDX clonIcebrg-3/31/2003
503Will have to give it some thought (and get around to reading the 10Ks in detail)nigel bates-3/31/2003
502Abgenix vs. Medarex. Based on Friday's closing prices Abgenix now has a marIcebrg-3/30/2003
501Latest HGSI mab is from CAT again - Message 18720806nigel bates-3/19/2003
500<i>(XOMA)</i>...License fee revenue in 2002 increased to $16.8 millinigel bates-3/11/2003
499Medarex's todo list for 2003. At today's BIO presentation DD presented Icebrg-2/27/2003
498Erik, Majority of your comments were correct. ABGX is today different story thaMiljenko Zuanic-2/20/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News